Institute of Neural Tissue Engineering, Mudanjiang College of Medicine, Mudanjiang 157011, People's Republic of China.
J Neural Eng. 2019 Aug 12;16(5):056011. doi: 10.1088/1741-2552/ab3188.
Our previous study demonstrated that the transcription factor, Krüppel-like Factor 7 (KLF7), stimulates axon regeneration following peripheral nerve injury. In the present study, we used a gene therapy approach to overexpress KLF7 in bone marrow-derived stem/stromal cells (BMSCs) as support cells, combined with acellular nerve allografts (ANAs) and determined the potential therapeutic efficacy of a KLF7-transfected BMSC nerve graft transplantation in a rodent model for sciatic nerve injury and repair.
We efficiently transfected BMSCs with adeno-associated virus (AAV)-KLF7, which were then seeded in ANAs for bridging sciatic nerve defects.
KLF7 overexpression promotes proliferation, survival, and Schwann-like cell differentiation of BMSCs in vitro. In vivo, KLF7 overexpression promotes transplanted BMSCs survival and myelinated fiber regeneration in regenerating ANAs; however, KLF7 did not improve Schwann-like cell differentiation of BMSCs within in the nerve grafts. KLF7-BMSCs significantly upregulated expression and secretion of neurotrophic factors by BMSCs, including nerve growth factor, ciliary neurotrophic factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in regenerating ANA. KLF7-BMSCs also improved motor axon regeneration, and subsequent neuromuscular innervation and prevention of muscle atrophy. These benefits were associated with increased motor functional recovery of regenerating ANAs.
Our findings suggest that KLF7-BMSCs promoted peripheral nerve axon regeneration and myelination, and ultimately, motor functional recovery. The mechanism of KLF7 action may be related to its ability to enhance transplanted BMSCs survival and secrete neurotrophic factors rather than Schwann-like cell differentiation. This study provides novel foundational data connecting the benefits of KLF7 in neural injury and repair to BMSC biology and function, and demonstrates a potential combination approach for the treatment of injured peripheral nerve via nerve graft transplant.
我们之前的研究表明,转录因子 Krüppel 样因子 7(KLF7)可刺激周围神经损伤后的轴突再生。在本研究中,我们使用基因治疗方法在骨髓来源的干细胞/基质细胞(BMSC)中过表达 KLF7 作为支持细胞,结合去细胞异体神经移植物(ANA),并确定 KLF7 转染的 BMSC 神经移植物移植在大鼠坐骨神经损伤和修复模型中的潜在治疗效果。
我们用腺相关病毒(AAV)-KLF7 有效地转染 BMSC,然后将其接种在 ANA 中以桥接坐骨神经缺损。
KLF7 过表达促进了 BMSC 的体外增殖、存活和许旺细胞样分化。在体内,KLF7 过表达促进了移植的 BMSC 在再生的 ANA 中的存活和有髓神经纤维的再生;然而,KLF7 并没有改善神经移植物内 BMSC 的许旺细胞样分化。KLF7-BMSC 显著上调了再生 ANA 中 BMSC 的神经营养因子的表达和分泌,包括神经生长因子、睫状神经营养因子、脑源性神经营养因子和胶质细胞源性神经营养因子。KLF7-BMSC 还改善了运动轴突的再生,以及随后的运动神经支配和肌肉萎缩的预防。这些益处与再生 ANA 运动功能的恢复有关。
我们的发现表明,KLF7-BMSC 促进了周围神经轴突的再生和髓鞘形成,最终促进了运动功能的恢复。KLF7 作用的机制可能与其增强移植的 BMSC 存活和分泌神经营养因子的能力有关,而不是与许旺细胞样分化有关。本研究为 KLF7 在神经损伤和修复中的作用与 BMSC 生物学和功能之间提供了新的基础数据,并展示了一种通过神经移植物移植治疗受损周围神经的潜在联合方法。